| [1] |
Holst JJ,Vilsboll T,Deacon CF.The incretin system and its role in type 2 diabetes mellitus[J].Mol Cell Endocrinol,2009,297(1/2):127-136.
|
| [2] |
Li C,Huan Y,Shen N,et al.A novel GLP-1 analog,BPI3006,with potent DPP IV resistance and good glucoregulatory effect[J].Biochem Biophys Res Commun,2010,400(4):563-568.
|
| [3] |
Lee CY. Glucagon-like peptide-1 formulation-the present and future development in diabetes treatment[J].Basic Clin Pharmacol Toxicol,2016,118(3):173-180.
|
| [4] |
de Boer MP,Meijer RI,Richter EA,et al.Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPK2[J].Vascul Pharmacol,2016,78:24-35.
|
| [5] |
Adya R,Tan BK,Randeva HS.Differential effects of leptin and adiponectin in endothelial angiogenesis[J].J Diabetes Res,2015,doi: 10.1155/2015/648239.
|
| [6] |
Ge H,Xiong Y,Lemon B,et al.Generation of novel long-acting globular adiponectin molecules[J].J Mol Biol,2010,399(1):113-119.
|
| [7] |
Bhatti AB,Usman M.Drug targets for oxidative podocyte injury in diabetic nephropathy[J].Cureus,2015,7(12):e393.
|
| [8] |
Gao M,Tong Y,Li W,et al.Improving the anti-diabetic activity of GLP-1 by fusion with globular adiponectin[J].Artif Cells Nanomed Biotechnol,2013,41(3):159-164.
|
| [9] |
Yamaguchi S,Yamamoto E,Mannen T,et al.Protein refolding using chemical refolding additives[J].Biotechnol J,2013,8(1):17-31.
|
| [10] |
Cai Y,Zhang Z,Fan K,et al.Pharmacokinetics,tissue distribution,excretion,and antiviral activity of PEGylated recombinant human consensus interferon-variant in monkeys,rats and guinea pigs[J].Regul Pept,2012,173(1/2/3):74-81.
|
| [11] |
Gao M,Jin Y,Tong Y,et al.A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo[J].J Pharm Pharmacol,2012,64(11):1646-1653.
|
| [12] |
Wu J,Lu S,Zheng Z,et al.Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins[J].Prep Biochem Biotechnol,2016,46(8):788-797.
|
| [13] |
da-Silva-Freitas D,Boldrini-Franca J,Arantes EC.PEGylation:a successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease[J].Protein Pept Lett,2015,22(12):1133-1139.
|
| [14] |
El-Shishtawy SH,Mosbah O,Sherif N,et al.Association between serum visfatin and carotid atherosclerosis in diabetic and non-diabetic patients on maintenance hemodialysis[J].Electron Physician,2016,8(2):1966-1972.
|
| [15] |
Nan MH,Park JS,Myung CS.Construction of adiponectin-encoding plasmid DNA and gene therapy of non-obese type 2 diabetes mellitus[J].J Drug Target,2010,18(1):67-77.
|
| [16] |
Zhong J,Cai X,Liu C,et al.Purification and conformational changes of bovine PEGylated-lactoglobulin related to antigenicity[J].Food Chem,2016,199:387-392.
|
| [17] |
Moosmann A,Muller E,Bottinger H.Purification of PEGylated proteins,with the example of PEGylated lysozyme and PEGylated scFv[J].Methods Mol Biol,2014,1129:527-538.
|
| [18] |
Fee CJ,Van Alstine JM.Purification of pegylated proteins[J].Methods Biochem Anal,2011,54:339-362.
|
下载:
